Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Global Tuberculosis Control - Surveillance, Planning, Financing, 2006 [[electronic resource] ] : WHO report 2006
| Global Tuberculosis Control - Surveillance, Planning, Financing, 2006 [[electronic resource] ] : WHO report 2006 |
| Autore | Malaria World Health Organization. Global Partnership to Roll Back |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2006 |
| Descrizione fisica | 1 online resource (250 p.) |
| Disciplina | 362.1/969792 |
| Soggetto topico |
Tuberculosis -- Epidemiology -- Statistics
Tuberculosis -- Epidemiology Tuberculosis -- Prevention -- Statistics Tuberculosis -- Prevention Tuberculosis |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-43629-8
9786610436293 92-4-068047-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preliminaries; Contents; Methods Monitoring progress in TB control; Results Monitoring progress in TB control; Conclusions Monitoring progress in TB control; Annex 1 Profi les of high-burden countries; Annex 2 Regional and country data |
| Record Nr. | UNINA-9910450415803321 |
Malaria World Health Organization. Global Partnership to Roll Back
|
||
| Geneva, : World Health Organization, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Global Tuberculosis Control - Surveillance, Planning, Financing, 2006 [[electronic resource] ] : WHO report 2006
| Global Tuberculosis Control - Surveillance, Planning, Financing, 2006 [[electronic resource] ] : WHO report 2006 |
| Autore | Malaria World Health Organization. Global Partnership to Roll Back |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2006 |
| Descrizione fisica | 1 online resource (250 p.) |
| Disciplina | 362.1/969792 |
| Soggetto topico |
Tuberculosis -- Epidemiology -- Statistics
Tuberculosis -- Epidemiology Tuberculosis -- Prevention -- Statistics Tuberculosis -- Prevention Tuberculosis |
| ISBN |
1-280-43629-8
9786610436293 92-4-068047-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preliminaries; Contents; Methods Monitoring progress in TB control; Results Monitoring progress in TB control; Conclusions Monitoring progress in TB control; Annex 1 Profi les of high-burden countries; Annex 2 Regional and country data |
| Record Nr. | UNINA-9910783715503321 |
|
Malaria World Health Organization. Global Partnership to Roll Back
|
||
| Geneva, : World Health Organization, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Guidelines on the Management of Latent Tuberculosis Infection [[electronic resource]]
| Guidelines on the Management of Latent Tuberculosis Infection [[electronic resource]] |
| Pubbl/distr/stampa | World Health Organization, 2015 |
| Descrizione fisica | 1 online resource (38 p.) |
| Disciplina | 616.109236 |
| Soggetto topico |
Tuberculosis -- Patients -- Treatment
Tuberculosis -- Prevention Tuberculosis -- Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN | 92-4-069352-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover""; ""Cover""; ""Contents""; ""Contents""; ""Acknowledgements""; ""Acknowledgements""; ""Abbreviations""; ""Abbreviations""; ""Declaration and management of conflict of interest""; ""Declaration and management of conflict of interest""; ""Executive summary""; ""Executive summary""; ""1. Background and process""; ""1. Background and process""; ""1.1. Background""; ""1.1. Background""; ""1.2. Scope of the guidelines""; ""1.2. Scope of the guidelines""; ""1.3. Target audience""; ""1.3. Target audience""; ""1.4. Development of the guidelines""; ""1.4. Development of the guidelines""
""1.5. Quality of evidence and strength of the recommendations""""1.5. Quality of evidence and strength of the recommendations""; ""2. Recommendations""; ""2. Recommendations""; ""2.1. Identification of at-risk populations for LTBI testing and treatment""; ""2.1. Identification of at-risk populations for LTBI testing and treatment""; ""2.1.1. Summary of the evidence""; ""2.1.1. Summary of the evidence""; ""2.1.2. Balance of benefits and harms""; ""2.1.2. Balance of benefits and harms""; ""2.1.3. Values and preferences of clients and health-care providers"" ""2.1.3. Values and preferences of clients and health-care providers""""2.1.4. Resource considerations""; ""2.1.4. Resource considerations""; ""2.2. Algorithm to test and treat LTBI""; ""2.2. Algorithm to test and treat LTBI""; ""2.2.1. Summary of the evidence""; ""2.2.1. Summary of the evidence""; ""2.2.2. Balance of benefits and harms""; ""2.2.2. Balance of benefits and harms""; ""2.2.3. Values and preferences of clients and health-care providers""; ""2.2.3. Values and preferences of clients and health-care providers""; ""2.2.4. Resource considerations""; ""2.2.4. Resource considerations"" ""2.3. Treatment options for LTBI""""2.3. Treatment options for LTBI""; ""2.3.1. Summary of the evidence""; ""2.3.1. Summary of the evidence""; ""2.3.2. Balance of benefits and harms""; ""2.3.2. Balance of benefits and harms""; ""2.3.3. Values and preferences of clients and health-care providers""; ""2.3.3. Values and preferences of clients and health-care providers""; ""2.3.4. Resource considerations""; ""2.3.4. Resource considerations""; ""2.4. Preventive treatment for contacts of MDR-TB cases""; ""2.4. Preventive treatment for contacts of MDR-TB cases""; ""2.4.1. Summary of the evidence"" ""2.4.1. Summary of the evidence""""2.4.2 Balance of benefits and harms""; ""2.4.2 Balance of benefits and harms""; ""2.4.3. Values and preferences of clients and health-care providers""; ""2.4.3. Values and preferences of clients and health-care providers""; ""2.4.4. Resource considerations""; ""2.4.4. Resource considerations""; ""2.4.5. Conclusions""; ""2.4.5. Conclusions""; ""3. Issues in Implementation""; ""3. Issues in Implementation""; ""3.1. Adverse events monitoring""; ""3.1. Adverse events monitoring""; ""3.2. Risk of drug resistance following LTBI treatment"" ""3.2. Risk of drug resistance following LTBI treatment"" |
| Record Nr. | UNINA-9910459728203321 |
| World Health Organization, 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
